Pacichana, J.A.; Osorio, L.M.; Restrepo, K.; GarcÃa, A.F.; Rivas, G.; Liscano, Y.
Diabetic Ketoacidosis as a Debut and Immune-Mediated Complication Caused by Pembrolizumab: Case Report. Diabetology 2024, 5, 600-607.
https://doi.org/10.3390/diabetology5060043
AMA Style
Pacichana JA, Osorio LM, Restrepo K, GarcÃa AF, Rivas G, Liscano Y.
Diabetic Ketoacidosis as a Debut and Immune-Mediated Complication Caused by Pembrolizumab: Case Report. Diabetology. 2024; 5(6):600-607.
https://doi.org/10.3390/diabetology5060043
Chicago/Turabian Style
Pacichana, Julian Andrés, Luis Miguel Osorio, Katherine Restrepo, Andres Felipe GarcÃa, Giovanna Rivas, and Yamil Liscano.
2024. "Diabetic Ketoacidosis as a Debut and Immune-Mediated Complication Caused by Pembrolizumab: Case Report" Diabetology 5, no. 6: 600-607.
https://doi.org/10.3390/diabetology5060043
APA Style
Pacichana, J. A., Osorio, L. M., Restrepo, K., GarcÃa, A. F., Rivas, G., & Liscano, Y.
(2024). Diabetic Ketoacidosis as a Debut and Immune-Mediated Complication Caused by Pembrolizumab: Case Report. Diabetology, 5(6), 600-607.
https://doi.org/10.3390/diabetology5060043